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Mitochondria are important organelles for energy production, Ca2+ homeostasis, and cell death. In recent years, the role of the mitochondria in both
apoptotic and necrotic cell death has received much attention. In apoptotic and necrotic death, an increase of mitochondrial membrane permeability is
considered to be one of the key events, although the detailed mechanism remains to be elucidated. The mitochondrial membrane permeability transition
(MPT) is a Ca2+-dependent increase in the permeability of the mitochondrial membrane that leads to loss ofΔψ, mitochondrial swelling, and rupture of the
outer mitochondrial membrane. The MPT is thought to occur after the opening of a channel, which is termed the permeability transition pore (PTP) and
putatively consists of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocator (ANT), cyclophilin D (Cyp D: a mitochondrial
peptidyl prolyl-cis, trans-isomerase), and other molecule(s). Our studies of mice lacking Cyp D have revealed that it is essential for occurrence of theMPT
and that the Cyp D-dependent MPT regulates some forms of necrotic cell death, but not apoptotic death. We have also shown that two anti-apoptotic
proteins, Bcl-2 and Bcl-xL, block the MPT by directly inhibition of VDAC activity. Here we summarize a role of the MPT in cell death.
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Apoptosis is the best-characterized form of programmed cell
death and an outline of its molecular basis is now well under-
stood. Mammalian cells possess two major apoptotic signaling
pathways, which are known as the intrinsic pathway and the
extrinsic pathway [1]. Mitochondria play a crucial role in the
intrinsic pathway: an increase of outer membrane permeability
leads to release of proteins from the intermembrane space into
the cytoplasm, including apoptogenic molecules such as
cytochrome c, Smac/Diablo, HtrA2 (Omi), AIF, and DNaseG
[1,2]. In the presence of ATP (dATP), cytochrome c binds to
Apaf-1 and triggers its oligomerization, after which pro-caspase-
9 is recruited and undergoes autoactivation. Thus, an increase in
the permeability of the outer mitochondrial membrane is central
to apoptosis [3,4], and membrane permeability is directly
regulated by the Bcl-2 family of proteins [4,5] (see Fig. 1).
However, the detailed mechanisms controlling outer mitochon-
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model used to explain the apoptotic increase of mitochondrial
membrane permeability was the “mitochondrial membrane
permeability transition” (MPT) [6], which has been known for
some time among investigators of the mitochondria.
2. MPT
Under various conditions, such as in the presence of Ca2+
togetherwith inorganic phosphate, isolatedmitochondria undergo
the MPT. This process is characterized by a Ca2+-dependent
increase in the permeability of the innermitochondrial membrane,
resulting in the loss ofΔψ, mitochondrial swelling, and rupture of
the outer mitochondrial membrane [7,8] (see Fig. 1). The MPT is
thought to occur after the opening of a putative channel complex,
which has been termed the permeability transition pore (PTP), and
consists of the voltage-dependent anion channel (VDAC: outer
membrane channel), the adenine nucleotide translocator (ANT:
inner membrane channel), cyclophilin D (Cyp D), and other
molecule(s) [9] (see Fig. 2). The exact nature of this complex is
still to be determined. A role of ANT in the MPT is supported by
inhibition or activation of the MPT by bonkrekic acid and
Fig. 1. Involvement of the mitochondria in apoptosis and necrosis. During apoptosis, an increase in the permeability of the outer mitochondrial membrane is crucial and
is regulated by multidomain pro-apoptotic members of the Bcl-2 family (Bax and Bak), resulting in the release of several apoptogenic factors into the cytoplasm. In
contrast, the Cyp D-dependent MPT (increased permeability of both the outer and inner mitochondrial membranes) is involved in necrosis induced by Ca2+ overload
and oxidative stress. Both kinds of mitochondrial membrane permeability changes are inhibited by anti-apoptotic members of the Bcl-2 family (Bcl-2 and Bcl-x).
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mitochondrial member of the cyclophilin family, which shows
peptidyl prolyl-cis, trans-isomerase (PPIase) activity and has a
crucial role in protein folding [11]. The presumed role of CypD in
regulating theMPT is based on the observation that cyclosporin A
(CsA), a specific inhibitor of the cyclophilin family, blocks the
MPT [12]. Cyp D resides in the mitochondrial matrix, but
associates with the inner mitochondrial membrane during the
MPT. Based on the enzymatic activity of Cyp D (PPIase), it is
suggested to induce a conformational change of an inner
membrane channel such as ANT, leading to an increase of innerFig. 2. Putative protein compmembrane permeability. In addition to the CsA-sensitive and Ca2
+-dependent (“regulated”) MPT, the existence of a CsA-
insensitive and Ca2+-independent (“unregulated”) MPT has also
been suggested, although its mechanism and relationship to the
CsA-sensitive MPT are totally unknown [13].
Some forms of apoptosis can be inhibited by CsA, suggesting
a role of the CsA-sensitive MPT in this process of cell death
[9,14]. The possible role of the MPT in apoptosis is also
supported by the finding that apoptosis is sometimes inhibited
by bonkrekic acid [10,15], although difficulty in using bonkrekic
acid as a potent inhibitor of apoptosis has often been noted bylex mediating the MPT.
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implicated in the remodeling of mitochondrial cristae and
mobilization of cytochrome c stores from the cristae during
apoptosis, thus promoting the complete release of cytochrome c
[16]. However, the overall role of the MPT in apoptosis remains
controversial because there have been a number of reports that
apoptosis is not inhibited by CsA [17]. Furthermore, it has been
demonstrated that Δψ follows cytochrome c release in at least
some types of apoptosis, suggesting that the MPT is not always
the cause of cytochrome c release and cell death.
3. Essential players in the MPT
It has long been considered that the VDAC, ANT, and Cyp D
play an essential role in the MPT, although convincing evidence
was lacking until very recently.
VDAC: Experimental evidence for a direct role of the VDAC
in the MPT has been provided by studies using anti-VDAC
antibodies [18] (Shimizu et al., 2001). Two polyclonal anti-
VDAC antibodies were obtained that recognized different
epitopes of the channel, and could inhibit VDAC activity as
assessed in liposomes [18]. Both of these anti-VDAC antibodies
also inhibited the Ca2+-induced MPT [18], supporting a crucial
role for VDAC in the MPT.
ANT: The ANTs (ANT1 and 2 in mice and ANT1, 2, and 3 in
humans) have also been considered important for occurrence of
the MPT. It has been demonstrated that Cyp D directly interacts
with ANT, although it is not known whether CsA inhibits the
interaction of Cyp D and ANT [19,20]. Regarding the role of
ANT in the MPT, considerable progress was made recently: it
was shown that liver mitochondria from mice lacking both
ANT1 and ANT2 underwent the MPT, although the threshold
for Ca2+ was slightly increased [21], suggesting that the ANT1/2
played only a limited role, if any, in the MPT or deficiency of
ANT1/2 might be compensated by other channel(s). Other
channel(s) involved in the MPT might be ANT-like channels on
the inner membrane, given that the MPT is modulated by ANT
ligands such as bonkrekic acid or atractyloside and that the MPT
is accompanied by Δψ loss (increased permeability of the inner
mitochondrial membrane). Identification of channel(s) in the
inner mitochondrial membrane, which is directly involved in the
MPT and might be a target of Cyp D, would be crucial.
Cyp D: A role of Cyp D in the MPT was initially suggested
because the MPT is inhibited by CsA, which inhibits the PPIase
activity of cyclophilins. This has recently been confirmed by
generation of Cyp D gene (ppif)-deficient mice [22–25]: Cyp D-
deficient mitochondria isolated frommouse livers do not undergo
the CsA-sensitive MPT in response to a variety of MPT inducers,
including Ca2+, atractyloside, and H2O2. Because the MPT does
not occur, these mitochondria accumulate a much larger amount
of Ca2+ than control mitochondria [22,25]. However, these Cyp
D-deficient mitochondria still undergo the CsA-insensitive MPT
in response to high concentrations of Ca2+ [22,24]. In addition,
the response to reagents like ubiquinone and thiol oxidants that
cause the CsA-insensitive MPT is normal in Cyp D-deficient
mitochondria [24]. Thus, Cyp D is specifically involved in the
CsA-sensitive MPT.4. No role of Cyp D-dependent MPT in apoptosis
It has been controversial as to whether the MPT plays an
important role in the apoptotic increase of mitochondrial
membrane permeability, but recent development of Cyp D-
deficient mice has finally solved this issue. Various cells isolated
from Cyp D-deficient mice, such as thymocytes, MEFs, and
hepatocytes, undergo apoptosis normally in response to various
stimuli, including etoposide, stautosporine, and TNFα [22–25],
providing the most compelling evidence that the MPT is not
essential for apoptosis. These observations certainly do not
exclude the possibility that some apoptosis might bemediated by
the CsA-sensitive MPT, and thus may be inhibited by CsA.
However, the inhibitory effect of CsA on apoptosis might need
to be more carefully evaluated because CsA is normally used at
relatively high concentrations that could inhibit other targets and
have a secondary effect on apoptosis. It may be necessary to re-
evaluate the inhibition of apoptosis by using Cyp D-deficient
cells or by silencing Cyp D in cells to assess the real effect of
CsA.
There have been several reports that overexpression of Cyp D
protects cells against some forms of apoptosis. For example, Cyp
D overexpression inhibits apoptosis induced by the over-
expression of caspase-8 (but not Bax) or by exposure to arsenic
trioxide [26,27]. These observations are apparently inconsistent
with the findings obtained using Cyp D-deficient cells. It might
be possible that apoptosis is mediated by the MPT, which is
somehow affected by overexpression of Cyp D in these
circumstances. However, studies of transgenic mice with
myocardial expression of Cyp D have revealed that cardiac
myocytes from these mice are prone to undergo mitochondrial
swelling and spontaneous death [23].
5. Involvement of the MPT in necrosis
In contrast to the lack of any impact of Cyp D deficiency on
apoptosis, the Cyp D-dependent MPTseems to play an important
role in some forms of necrotic cell death (see Fig. 1). It has been
shown that CypD-deficientMEFs are significantly more resistant
to H2O2-induced necrosis [22,23], while Cyp D-deficient
hepatocytes gain resistance to necrosis induced by a Ca2+
ionophore (A23187) or by H2O2 [22,23]. Interestingly, when
necrosis is inhibited by Cyp D-deficiency in these cells, apoptosis
does not occur as an alternate death mechanism [22], suggesting
that these cells somehow block the apoptotic signaling pathway
activated by H2O2 and Ca
2+ overload.
6. Regulation of the MPT by Bcl-2
Although anti-apoptotic members of the Bcl-2 family (Bcl-2
and Bcl-xL) are known to inhibit the Bax/Bak-dependent
apoptotic increase of mitochondrial membrane permeability by
direct interaction with pro-apoptotic members of this family, they
have also been shown to inhibit theMPT [28,29](see Fig. 1). How
do these proteins act to block the MPT? Since Bax/Bak is not
essential for the MPT [22], Bcl-2 (Bcl-x) might directly inhibit a
component of the PTP complex. This concept is supported by the
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suggesting that Bcl-2 may inhibit the MPT via VDAC blockade.
It has also been shown that Bcl-2 can inhibit ANT activity [30]
(Marzo et al., 1998b). However, ANTmight not be a major player
of the MPT [21], as described above, so Bcl-2 might inhibit other
unidentified channels similar to ANT that are actually involved in
the MPT. Since Bcl-2 resides mainly on the outer mitochondrial
membrane, it is likely to act on the MPT by inhibiting VDAC.
7. Future studies
Studies using Cyp D-deficient mice enabled us to provide
convincing evidence that the Cyp D-dependent MPT does not
play a role in apoptosis. However, there are still many important
questions to be answered:
(1) What is the molecular nature of the MPT pore complex?
(2) What is the target of Cyp D and how does Cyp D induce the
MPT? (3) What is the biological significance of the MPT? (4)
What is the relationship between the Cyp D-dependent MPT
and the unregulated MPT? (5) Does the unregulated MPT have
a role in apoptosis or other forms of cell death? Further studies
are needed to answer these important questions.
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